Ray Dalio
EHC icon

Ray Dalio’s Encompass Health EHC Stock Holding History

Ray Dalio’s Portfolio EHC Stock Details EHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.15M Sell
41,016
-5,399
-12% -$559K 0.02% 517
2026
Q1 		$4.49M Buy
46,415
+11,023
+31% +$1.13M 0.02% 446
2025
Q4 		$3.76M Sell
35,392
-22,406
-39% -$2.6M 0.01% 613
2025
Q3 		$7.34M Buy
57,798
+54,535
+1,671% +$6.49M 0.03% 398
2025
Q2 		$400K Sell
3,263
-970
-23% -$111K ﹤0.01% 538
2025
Q1 		$429K Sell
4,233
-6,545
-61% -$639K ﹤0.01% 582
2024
Q4 		$995K Sell
10,778
-5,362
-33% -$526K ﹤0.01% 506
2024
Q3 		$1.56M Sell
16,140
-41,537
-72% -$3.73M 0.01% 547
2024
Q2 		$4.95M Sell
57,677
-3,286
-5% -$276K 0.03% 357
2024
Q1 		$5.03M Sell
60,963
-42,923
-41% -$3.14M 0.03% 377
2023
Q4 		$6.93M Buy
103,886
+34,356
+49% +$2.23M 0.04% 319
2023
Q3 		$4.67M Sell
69,530
-38,553
-36% -$2.65M 0.03% 372
2023
Q2 		$7.32M Sell
108,083
-11,704
-10% -$733K 0.05% 243
2023
Q1 		$6.48M Sell
119,787
-1,584
-1% -$92.2K 0.04% 267
2022
Q4 		$7.26M Sell
121,371
-37,943
-24% -$2.06M 0.04% 295
2022
Q3 		$7.21M Sell
159,314
-44,806
-22% -$2.24M 0.04% 313
2022
Q2 		$9.1M Buy
204,120
+19,946
+11% +$1.02M 0.04% 353
2022
Q1 		$10.4M Buy
184,174
+49,185
+36% +$2.57M 0.04% 291
2021
Q4 		$7.01M Buy
134,989
+22,416
+20% +$1.16M 0.04% 241
2021
Q3 		$6.72M Sell
112,573
-17,080
-13% -$1.07M 0.04% 253
2021
Q2 		$8.05M Buy
129,653
+125,690
+3,172% +$8.38M 0.05% 252
2021
Q1 		$258K Buy
+3,963
New +$258K ﹤0.01% 429

Other funds holding EHC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Ray Dalio's EHC Position: Q2 2026 in Review

Ray Dalio reduced its Encompass Health (EHC) stake by 12% in Q2 2026, selling an estimated $559K and leaving 41,016 shares worth $4.15M. The position accounts for 0.02% of the portfolio, ranked #517.

Ray Dalio first reported a position in EHC in Q1 2021 and has held it in 22 quarters since. The position peaked at $10.4M in Q1 2022. 599 funds tracked by Wall St. Rank hold EHC as of Q2 2026.

  • Ray Dalio held 41,016 shares of Encompass Health worth $4.15M as of Q2 2026.
  • Ray Dalio sold 5,399 Encompass Health shares in Q2 2026, an estimated $559K.
  • Encompass Health made up 0.02% of Ray Dalio's portfolio in Q2 2026, its #517 holding.
  • Ray Dalio first reported a position in Encompass Health in Q1 2021 and has held it in 22 quarters since.
  • Ray Dalio's Encompass Health position peaked at $10.4M in Q1 2022.
  • 599 funds tracked by Wall St. Rank held Encompass Health as of Q2 2026.

Based on Bridgewater Associates's 13F filing for Q2 2026, filed 14 Aug 2026.